Quantitative predictors of tumor severity

US10339648B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10339648-B2
Application numberUS-201414761688-A
CountryUS
Kind codeB2
Filing dateJan 21, 2014
Priority dateJan 18, 2013
Publication dateJul 2, 2019
Grant dateJul 2, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are methods for quantitatively predicting the severity of a tumor in a subject. In some embodiments, the methods further comprise selecting a course of therapy for the subject. In some embodiments, the tumor comprises is non-small cell lung cancer.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for quantitatively predicting the severity of a tumor in a subject, comprising receiving, using a processor, an anatomical image acquired from a region of interest in a subject containing the tumor, wherein the anatomical image is a computed tomography (CT) image; segmenting, using the processor, the anatomical image using a segmentation algorithm to define a volume of interest representing the tumor, thereby generating a segmented image of the tumor; extracting, using the processor, one or more image features from the segmented image of the tumor, wherein the one or more image features are selected from the group consisting of entropy or a combination of convexity and entropy; generating a quantitative score for the one or more image features, using the processor, wherein the quantitative score for the one or more image features is associated with tumor severity, and wherein the quantitative score for entropy is a ratio of the average entropy in a core region of the segmented image of the tumor to the average entropy in a boundary region of the segmented image of the tumor; and presenting, using the processor, the quantitative score to a user for selecting a course of therapy for the subject based on the quantitative score for the one or more image features. 2. The method of claim 1 , wherein the one or more image features is entropy. 3. The method of claim 1 , wherein the ratio is calculated by an algorithm that performs steps comprising: a) subdividing the segmented image of the tumor into the core region and the boundary region; b) calculating an entropy coefficient for each pixel in the core region and the boundary region; c) averaging the entropy coefficients for the core region and for the boundary region; and d) comparing the average entropy coefficient of the core region to the average entropy coefficient of the boundary region to obtain the entropy ratio. 4. The method of claim 1 , wherein the one or more image features further comprises convexity. 5. The method of claim 4 , wherein the convexity is calculated by an algorithm that performs steps comprising: a) identifying a border of the segmented image of the tumor; b) creating a mask of the segmented image of the tumor; c) calculating the area of the mask of the segmented image of the tumor; d) creating a convex hull of the border of the segmented image of the tumor; e) calculating the area of the convex hull; and f) comparing the area of the mask to the area of the convex hull to calculate convexity. 6. The method of claim 5 , wherein the algorithm for convexity further comprises correcting for overlap with a structure comprising: a) identifying a border of a structure; b) comparing the border of the structure with the border of the segmented image of the tumor to determine overlap between the segmented image of the tumor and the structure; and c) eliminating overlapping regions from the area of the mask of the segmented image of the tumor and the area of the convex hull used to calculate convexity. 7. The method of claim 1 , wherein the tumor comprises non-small cell lung cancer. 8. The method of claim 7 , wherein the tumor is a lung adenocarcinoma. 9. The method of claim 1 , wherein the method is combined with a tumor node metastasis (TNM) staging system to predict the severity of the tumor. 10. The method of claim 1 , wherein the anatomical image comprises a stack of two-dimensional image slices of the region of interest. 11. The method of claim 10 , wherein the method further comprises rendering the two-dimensional image slices into a three-dimensional image. 12. The method of claim 10 , wherein the wherein the quantitative score for convexity is calculated as the average convexity for each two-dimensional image slice. 13. The method of claim 1 , further comprising the step of acquiring the anatomical image of the region of interest in the subject containing the tumor. 14. The method of claim 1 , further comprising selecting a course of therapy for the subject based on the quantitative score for the one or more image features. 15. The method of claim 14 , wherein the quantitative score for convexity is an indication of either an irregular or a convex tumor shape, wherein the method comprises selecting adjuvant therapy for the subject if the quantitative score for convexity indicates an irregular tumor shape. 16. The method of claim 14 , wherein the quantitative score for entropy is an indication of tumor density, wherein the method comprises selecting adjuvant therapy for the subject if the quantitative score for entropy indicates a high tumor density. 17. A method of selecting a course of therapy for a subject based on the severity of a tumor in the subject, the method comprising: receiving a quantitative score for one or more image features extracted from a segmented image of the tumor, wherein: the quantitative score for the one or more image features is associated with tumor severity and the tumor comprises non-small cell lung cancer, the one or more image features are selected from the group consisting of entropy or a combination of convexity and entropy, the quantitative score for entropy is an indication of tumor density and is a ratio of the average entropy in a core region of the segmented image of the tumor to the average entropy in a boundary region of the segmented image of the tumor, and the quantitative score for convexity is an indication of either an irregular tumor shape or a convex tumor shape; and selecting a course of therapy for the subject based on the quantitative score for the one or more image features, wherein: when the quantitative score for entropy indicates a high tumor density, the method comprises selecting surgery and post-surgery adjuvant therapy for the subject, when the quantitative scope for entropy does not indicate a high tumor density, the method comprises selecting surgery for the subject, when the quantitative score for convexity indicates an irregular tumor shape, the method comprises selecting surgery and post-surgery adjuvant therapy for the subject, and when the quantitative score for convexity indicates a convex tumor shape, the method comprises selecting surgery for the subject.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10339648B2 cover?
Disclosed are methods for quantitatively predicting the severity of a tumor in a subject. In some embodiments, the methods further comprise selecting a course of therapy for the subject. In some embodiments, the tumor comprises is non-small cell lung cancer.
Who is the assignee on this patent?
H Lee Moffitt Cancer Ct & Res
What technology area does this patent fall under?
Primary CPC classification G06T7/0012. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).